Widgets for Webmasters
Emergent Biosolutions And University Of Oxford Form Joint Venture To Develop An Advanced...
medicalnewstoday.com 3 hrs ago 19 relatedThe University of Oxford and Emergent BioSolutions Inc. (NYSE:EBS) has announced that they have formed a joint venture, The Oxford-Emergent Tuberculosis Consortium Ltd. (the "Consortium"), to further develop MVA85A, the world's...

